Are there prostate cancer research studies?

At any given time, there are hundreds of prostate cancer clinical trials underway.

The Community Clinical Oncology Program (CCOP) was initiated by the National Cancer Institute (NCI) in 1983 to provide community hospitals access to a wide range of clinical research studies. Prior to this, a patient had to travel to one of a few select research institutions in the country or to the NCI itself to receive the newest treatments. This meant leaving familiar surroundings of home, family and workplace. As well, oncology physician specialists in your community wanted to be part of the search for answers to cure cancer and to offer you the best treatments available.

The NCI designates a CCOP once a hospital has met the stringent criteria set forth defining excellence in an oncology program. The Atlanta Regional CCOP is one of approximately 50 in the country. The Atlanta Regional CCOP consists of the coordinating institution (Saint Joseph's Hospital) and seven affiliate institutions, which virtually cover the entire metro Atlanta area.

Visit the Atlanta Regional CCOP website for a list of Clinical Trials available in the Atlanta area for prostate cancer.

The Bladder and Prostate Tissue Study (Molecular and Proteomic Analysis of Prostate and Bladder Tissue) is a collaborative research study co-sponsored by Saint Joseph's Hospital, Georgia Institute of Technology and Clark Atlanta University with the goal of examining the genetics and gene expression in bladder and prostate cancers. Learn more >> Spring 2011 Prostate Update newsletter. 

Resources for Clinical Trials:

National Cancer Institute allows you to search its list of 8,000+ clinical trials now accepting participants. Call the NCI at 1-800-4-CANCER with questions about Clinical Trials.

Information on this page is provided collaboratively by the team at the Prostate Cancer Center at Saint Joseph's and has been medically reviewed by Rajesh G. Laungani, MD, 2010. The PCC follows American Urological Association and  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for the treatment of prostate cancer.

Last Updated: March 9, 2011 (RSH)